Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04319419Not ApplicableCompleted

Milk Proteins and Micronutrient Supplementation in Obese Children

Role: collaborator

NCT03513991Not ApplicableCompleted

Evaluation of Different Protein Content of Formulas on Nutrition Status of Infants.

Role: collaborator

NCT01505023Phase 2Completed

Partial Meal Replacement and Inulin in Obese Women

Role: collaborator

All 3 trials loaded